Aidapak Recalls Quinapril HCL Tablets Due to Potential Label Mixup
Aidapak Services, LLC is recalling 20 mg Quinapril HCL tablets because they may be mislabeled as Multivitamin/Multimineral tablets.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically corresponds to a Moderate severity score (2) for minor labeling errors or low-risk contamination where the risk is temporary or medically reversible.
Plain-English summary
Aidapak Services, LLC is recalling 90-count bottles of Quinapril HCL, 20 mg tablets (NDC 68180-0558-09). The recall is due to a labeling mixup where the product may be mislabeled as Multivitamin/Multimineral tablets (NDC 65162-0668-50). The affected product has pedigree W003556 and an expiration date of 6/24/2014.
The repacked drugs were distributed in Arizona, California, Oregon, and Washington. This recall is classified as FDA Class II, indicating that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
Consumers who have this product should contact their healthcare provider or pharmacist for guidance. The source text does not specify a specific action for consumers beyond the standard recall notification, but typically, patients should stop using the product and seek a replacement or alternative treatment from their prescriber.
The recalled product
- Product
- QUINAPRIL HCL, Tablet, 20 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 68180055809
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 90
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- QUINAPRIL HCL
- Tablet
- 20 mg has the following code Pedigree: W003556
- EXP: 6/24/2014.
Distribution
Part of a larger recall action
This product is one of 273 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 273 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- SevereBetter Bakehouse Recalls Donutful Chocolate Dipped Vanilla Cake Donuts for Undeclared Milk
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- LowMindray ePM Series Patient Monitor Manuals Recalled for Alarm Clarification
FDA (Devices) · 2026-10-14
Similar recalls
- ModerateAidapak Multivitamin Chew Tablets Recalled for Potential Label Mixup
FDA (Drugs) · 2014-01-29
- SevereFDA Recalls Mislabeled Quinidine Sulfate Tablets Distributed by Aidapak
FDA (Drugs) · 2014-01-29
- SevereAidapak Recalls Multivitamin Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- SevereAidapak Recalls Thiamine HCL Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Imipramine Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Dicyclomine HCL Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29